Dutch TV show Koffietijd broadcasts interview with Suzanne Wolf on access to vaccines for children
Wednesday, 6 January 2016
Access to Vaccines Index
On the popular Dutch TV show Koffietijd (Coffeetime) presenter Pernille La Lau interviewed Suzanne Wolf, Director of Communications at the Access to Medicine Foundation about how vaccines save lives and protect children from the threat of disease.
Suzanne Wolf, Director of Communications at the Access to Medicine Foundation, talks with Dutch TV presenter Pernille La Lau on Koffietijd (Coffeetime), about how vaccines save lives and protect children from the threat of disease. The newly launched Access to Vaccines Index is a new tool for spurring industry change and for improving access to vaccines for everyone. (Vaccins voor iedereen). This Index is sponsored by the Dutch National Postcode Lottery.
About the Access to Vaccines Index
The 2017 Access to Vaccines Index will provide an initial baseline of industry activity regarding access to vaccines. It will examine where and how companies are already taking action, and bring good practices to the attention of other companies and stakeholders working in the vaccines space. These organisations will be able to use the Index to inform priorities and strategies, and to clarify where new incentives are needed to spur greater positive change. During 2016, the Foundation’s research team will analyse the data captured by the first Access to Vaccines Index, which will be published early in 2017. The Access to Vaccines Index is funded by the Dutch National Postcode Lottery.
About the Access to Medicine Foundation
The Access to Medicine Foundation is a non-profit organisation based in the Netherlands. It aims to advance access to medicine in low- and middle-income countries by stimulating and guiding the pharmaceutical industry to play a greater role in improving access to medicine. The Foundation is funded by the Bill & Melinda Gates Foundation, the Dutch Ministry of Foreign Affairs and the UK Department for International Development. For ten years, the Foundation has been building consensus on the role for the pharmaceutical industry in improving access to medicine and vaccines. It published its first benchmark of industry activity in this area in 2008, in the first Access to Medicine Index. The fifth Access to Medicine Index will be published in 2016.